Given the complexity of Osteoarthritis with its multiple factors and genetic components, it is not only difficult to classify—it is difficult to treat. While traditional methods of managing OA include prescription injections, ongoing physical therapy and high-risk surgical interventions, there’s a promising alternative for osteoarthritis – ReNu. As a single-injection therapy, ReNu contains hyaluronic acid, cellular compounds and extracellular matrix proteins. Interestingly, it is a natural bioactive amniotic suspension fluid that has been derived from donated materials following a normal caesarean section. To further explain, the amniotic membrane is the inner layer of the placenta, while amniotic fluid is the fluid surrounding a fetus in the uterus. Continue reading.